发明名称 |
MODULATORS OF SYNDECAN-2 AND USES THEREOF |
摘要 |
Modulators of syndecan-2, such as an antibody to syndecan-2 that cross-links syndecan-2 on the cell surface or a syndiecan-2 polypeptide that interferes with syndecan-2 receptor binding, is used to regulate a Th17 mediated disease such as an autoimmune disease, fibrosis or cancer. |
申请公布号 |
US2016271211(A1) |
申请公布日期 |
2016.09.22 |
申请号 |
US201615074681 |
申请日期 |
2016.03.18 |
申请人 |
Orbsen Therapeutics Limited |
发明人 |
ELLIMAN Stephen J.;BARKLEY Laura Rose;KAVANAUGH Jack |
分类号 |
A61K38/17;A61K35/17;A61K9/00;A61K35/545;A61K45/06;A61K9/08 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of treating at least one disorder selected from the list consisting of an autoimmune disorder, fibrosis and a cancer, comprising the steps of
identifying a subject in need of treatment for at least one disorder selected from the list consisting of an autoimmune disorder, a fibrotic disorder and a cancer; and administering a dosage regimen of a Th17 inhibitor to the subject. |
地址 |
Galway IE |